In the Matter of Xonics Photochemical, Inc., Debtor. Appeal of Mitsui and Company (u.s.a.), Inc

841 F.2d 198, 18 Collier Bankr. Cas. 2d 711, 1988 U.S. App. LEXIS 3035, 17 Bankr. Ct. Dec. (CRR) 606, 1988 WL 19070
CourtCourt of Appeals for the Seventh Circuit
DecidedMarch 8, 1988
Docket87-2143
StatusPublished
Cited by163 cases

This text of 841 F.2d 198 (In the Matter of Xonics Photochemical, Inc., Debtor. Appeal of Mitsui and Company (u.s.a.), Inc) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In the Matter of Xonics Photochemical, Inc., Debtor. Appeal of Mitsui and Company (u.s.a.), Inc, 841 F.2d 198, 18 Collier Bankr. Cas. 2d 711, 1988 U.S. App. LEXIS 3035, 17 Bankr. Ct. Dec. (CRR) 606, 1988 WL 19070 (7th Cir. 1988).

Opinion

POSNER, Circuit Judge.

This bankruptcy case presents interesting questions concerning the status in bankruptcy of contingent liabilities and in-teraffiliate obligations. For background see Comment, Avoidability of Intercorpo-rate Guarantees Under Sections 548(a)(2) and 544(b) of the Bankruptcy Code, 64 N.C.L.Rev. 1099 (1986). Xonics, Inc., now in Chapter 11 bankruptcy, has several wholly owned subsidiaries that are engaged in making medical equipment. The largest is Xonics Medical Systems, Inc.; one of the smallest is Xonics Photochemical, Inc., the debtor in the proceeding before us. In 1982 and 1983, a time of prosperity for the Xonics family, Xonics Medical Systems borrowed some $16 to $20 million from a bank, on a $26 million credit line. Xonics, Inc., the parent, caused Xon-ics Photochemical, Inc. (along with the other subsidiaries) to guarantee the loan; at the time Xonics Photochemical had gross assets of some $2.6 million and net assets of $1.7 million. Xonics, Inc. also caused Xonics Photochemical to become a co-maker with Xonics Medical Systems of a note to secure an additional loan of $3 million.

Shortly after these transactions, Mitsui & Co. (U.S.A.), Inc., a supplier to Xonics Photochemical, shipped it some chemicals, and invoiced it for the purchase price, which was (approximately) $124,000. Xonics Photochemical paid the invoice with two checks that cleared in January 1984. Fewer than 90 days later, Xonics Photochemical was in bankruptcy. Xonics Medical Systems had defaulted on its bank loan, triggering the guarantees of its affiliates. The total assets of the Xonics family — all of which were pledged to the creditors of each member through guarantees similar to the one Xonics Photochemical had signed — were short of the total liabilities by many millions of dollars; so all the subsidiaries, as well as the parent, found themselves in Chapter 11.

Xonics Photochemical, as debtor in possession (no trustee in bankruptcy had been appointed), brought an adversary proceeding against Mitsui to set aside the two payments as preferences voidable under 11 U.S.C. § 547(b). This provision makes transactions voidable by the trustee, but 11 U.S.C. § 1107(a) gives the debtor in possession the powers of a trustee. The disposi-tive issue was whether Xonics Photochemical had been insolvent when the payments to Mitsui were made; that is, did the fair value of its liabilities exceed the fair value of its assets (11 U.S.C. § 101(31)(A))? If so, the payments were indeed voidable preferences, see 11 U.S.C. § 547(b)(3), since the other conditions in section 547(b) had been met. The bankruptcy judge and the district judge thought Xonics Photochemical had been insolvent then; Mitsui disagrees and has appealed.

The startling feature of the case is the parties’ apparent assent to the proposition that if the loan guarantee and the note that Xonics Photochemical had co-signed were valid obligations, Xonics Photochemical was insolvent as of the date the obligations were assumed, on the theory that they created liabilities greater than the company’s net assets (much greater: $28 million in liabilities versus less than $2 million in net assets). The proposition is absurd; it would mean that every individual or firm that had contingent liabilities greater than his or its net assets was insolvent — something no one believes. Every firm that is being sued or that may be sued, every individual who has signed an accommodation note, every bank that has issued a letter of credit, has a contingent liability. Such liabilities are occasionally *200 listed on the firm’s balance sheet, for example by earmarking a portion of surplus for contingent liabilities. (They are supposed to be listed “if the future event is likely to occur and if its amount can be reasonably estimated.” Nikolai et al., Intermediate Accounting 611 (3d ed. 1985) (emphasis in original).) More often they are listed in a footnote, thus leaving the firm’s stated net worth undisturbed. Often they are not listed at all, when they are remote or when they are too small to affect net worth substantially. On the proper accounting treatment of contingent liabilities see id. at 610-14; Faris, Accounting for Lawyers 362-64 (3d ed. 1975); Williams, Stanga & Holder, Intermediate Accounting 609-17 (1984); Meigs, Mosich & Johnson, Accounting: The Basis for Business Decisions 288 (3d ed. 1972); Financial Accounting Standards Board, FASB Statement of Standards No. 5 (1975).

There is a compelling reason not to value contingent liabilities on the balance sheet at their face amounts, even if that would be possible to do because the liability, despite being contingent, is for a specified amount (that is, even if there is no uncertainty about what the firm will owe if the contingency materializes). By definition, a contingent liability is not certain — and often is highly unlikely — ever to become an actual liability. To value the contingent liability it is necessary to discount it by the probability that the contingency will occur and the liability become real. Suppose that on the date the obligations were assumed there was a 1 percent chance that Xonics Photochemical would ever be called on to yield up its assets to creditors of Xonics Medical Systems (or other members of the Xonics family, since the system of guarantees had the effect of pooling their assets for the benefit of creditors of any member). Then the true measure of the liability created by these obligations on the date they were assumed would not be $28 million; it would be a paltry $17,000. For at worst Xonics Photochemical would have to yield up all of its assets (net of other liabilities), that is, $1.7 million, and the probability of this outcome is by assumption only 1 percent (we are ignoring intermediate possibilities — e.g., that Xonics Photochemical would be forced to cough up $1 million rather than $1.7 million). Discounted, the obligations would not make Xonics insolvent, and section 547(b) would not come into play unless events occurring between the assumption of the obligations in 1982 and 1983 and the bankruptcy in 1984 had altered the picture. We add that Xonics Photochemical did not in fact list these obligations as liabilities on its balance sheet.

The principle just outlined has long been recognized in cases dealing with the question whether a firm is insolvent within the meaning of the Bankruptcy Code (and this is such a case). It makes no difference whether the firm has a contingent asset or a contingent liability; the asset or liability must be reduced to its present, or expected, value before a determination can be made whether the firm’s assets exceed its liabilities. See, e.g., Syracuse Engineering Co. v. Haight, 97 F.2d 573, 576 (2d Cir.1938) (L. Hand, J.); In re Ollag Construction Equipment Corp., 578 F.2d 904, 909 (2d Cir.1978); In re Fulghum Construction Co., 7 B.R. 629, 632-33 (Bankr.M.D.Tenn.1980), aff’d, 14 B.R. 293 (M.D.Tenn.1981); In re Hemphill, 18 B.R. 38, 48-49 (Bankr.S.D.Iowa 1982).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sama v. Mullaney
S.D. New York, 2020
Weinman v. Crowley (In re Blair)
594 B.R. 712 (D. Colorado, 2018)
Schaumburg Bank &Trust Company v. Richard S. Alsterda
815 F.3d 306 (Seventh Circuit, 2016)
United States v. Equipment Acquisition Resource
742 F.3d 743 (Seventh Circuit, 2014)
In re: Midway Motor Sales v.
Sixth Circuit, 2009
Harris Bank, N.A. v. Werner (In Re Werner)
410 B.R. 797 (N.D. Illinois, 2009)
Cordes & Company, LLC v. Mitchell Companies, LLC
605 F. Supp. 2d 1015 (N.D. Illinois, 2009)
In Re FV Steel and Wire Co.
372 B.R. 446 (E.D. Wisconsin, 2007)
Paratransit Risk Retention Group Insurance Co. v. Kamins
160 P.3d 307 (Colorado Court of Appeals, 2007)
In Re Cable & Wireless, PLC, Securities Litigation
332 F. Supp. 2d 896 (E.D. Virginia, 2004)
Mellon Bank v. Dick Corporation
Seventh Circuit, 2003
In Re G-I Holdings, Inc.
292 B.R. 804 (D. New Jersey, 2003)
Cybergenics Corp v. Chinery
Third Circuit, 2002

Cite This Page — Counsel Stack

Bluebook (online)
841 F.2d 198, 18 Collier Bankr. Cas. 2d 711, 1988 U.S. App. LEXIS 3035, 17 Bankr. Ct. Dec. (CRR) 606, 1988 WL 19070, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-the-matter-of-xonics-photochemical-inc-debtor-appeal-of-mitsui-and-ca7-1988.